ArKa Foundation Divests 75% Stake in Med-Gastr to Tar Heel Capital
Deal News | Jun 25, 2025 | CEE Legal Matters
The article reports on the sale of a 75% stake in Centrum Medyczne Med-Gastr by the ArKa Foundation to Tar Heel Capital. Gessel and Sobczynscy i Partnerzy provided legal advice to the seller and buyer respectively. The transaction represents ArKa's exit from the colorectal oncology diagnostics provider. Tar Heel Capital, experienced in this sector, is expected to bring in growth financing, which will support the expansion and continuity of Med-Gastr's operations. The Gessel advisory team consisted of several key members including Managing Partner Marcin Macieszczak and Partner Aldona Pietrzak, among others.
Sectors
- Healthcare
- Private Equity
- Legal Advisory
Geography
- Poland – The transaction involves Polish entities, namely ArKa Foundation, Med-Gastr, and Tar Heel Capital.
Industry
- Healthcare – Med-Gastr is a specialized healthcare provider with a focus on colorectal oncology diagnostics.
- Private Equity – Tar Heel Capital, involved in the acquisition, is a private equity firm with sectoral experience.
- Legal Advisory – Both Gessel and Sobczynscy i Partnerzy provided legal advisory services in this transaction.
Financials
- 75% – Percentage stake in Med-Gastr sold by ArKa Foundation to Tar Heel Capital.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ArKa Foundation | Selling Company | Company | A family foundation that held a 75% stake in Centrum Medyczne Med-Gastr. |
| Centrum Medyczne Med-Gastr | Target Company | Company | A specialized healthcare provider focusing on early-stage colorectal oncology diagnostics. |
| Tar Heel Capital | Bidding Companybuyer | Company | A private equity firm acquiring a 75% stake in Med-Gastr. |
| Gessel | Legal Advisor | Company | Provided legal advice to ArKa Foundation on the transaction. |
| Sobczynscy i Partnerzy | Legal Advisor | Company | Provided legal advice to Tar Heel Capital. |